UMIN000052195
Efficacy and safety of antifibrotic agents for interstitial lung disease associated with rheumatoid arthritis
Yokohama City University Graduate School of Medicine·University Hospital Medical Information NetworkNot yet recruiting
Study focus
- Disease/Condition
- Rheumatoid arthritis
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Yokohama City University Graduate School of Medicine
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 01, 2024
- End date
- N/A
ICD-10 classifications
Rheumatoid arthritis, unspecifiedOther rheumatoid arthritisOther specified rheumatoid arthritisRheumatoid arthritis with involvement of other organs and systemsSeronegative rheumatoid arthritis
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000052195
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000052195 through Pure Global AI's free database. This phase not specified trial is sponsored by Yokohama City University Graduate School of Medicine and is currently Not yet recruiting. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.